Study to Evaluate the Efficacy & Safety of HIP2101 in Patients With Acute

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04289519` - Endoscopic Findings of Gastritis in Children
Recruiting	`NCT02353039` - Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis	Phase 2
Recruiting	`NCT05545397` - Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients
Not yet recruiting	`NCT05510388` - HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients	N/A
Completed	`NCT02724280` - Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy	N/A
Not yet recruiting	`NCT02961296` - Helicobacter Pylori Antibiotic Susceptibility Testing of Korea	N/A
Completed	`NCT02385045` - i-Scan for the Detection of Helicobacter Pylori	N/A
Completed	`NCT00212225` - Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)	N/A
Completed	`NCT04672018` - Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis	Phase 2
Not yet recruiting	`NCT05072938` - Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis	Phase 4
Completed	`NCT02597517` - New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy	N/A
Completed	`NCT02296021` - Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy	Phase 4
Completed	`NCT01576289` - Analysis of Biopsies From the Upper Gastrointestinal Tract	N/A
Active, not recruiting	`NCT03509831` - [KJ-INT-002] BE Study	Phase 1
Terminated	`NCT05579444` - Systems Biology of Gastrointestinal and Related Diseases
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed	`NCT05237115` - Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy	Phase 4
Completed	`NCT02393430` - Clinical Effect of Rebamipide on Chronic Gastritis	Phase 4
Completed	`NCT00579410` - Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule	N/A
Completed	`NCT00267475` - Data Bank for Eosinophilic Disorders	N/A

NCT number	NCT05024721
Study type	Interventional
Source	Hanmi Pharmaceutical Company Limited
Contact
Status	Completed
Phase	Phase 3
Start date	August 9, 2021
Completion date	March 7, 2022

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms